IFP Advisors’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.18K	Hold	124	–	–	﹤0.01%	4153
2025 Q4	$967	Sell	124 -565	-82%	-$4.08K	﹤0.01%	4082
2025 Q3	$5.23K	Sell	689 -39	-5%	-$325	﹤0.01%	3223
2025 Q2	$6.52K	Buy	728 +675	+1,274%	+$6.29K	﹤0.01%	3182
2025 Q1	$398	Hold	53	–	–	﹤0.01%	3511
2024 Q4	$399	Buy	+53	New	+$402	﹤0.01%	3480
2023 Q4	–	Sell	-25	Closed	-$177	–	3076
2023 Q3	$177	Hold	25	–	–	﹤0.01%	3204
2023 Q2	$176	Sell	25 -1	-4%	-$8	﹤0.01%	3325
2023 Q1	$162	Sell	26 -5,517	-100%	-$53.1K	﹤0.01%	3287
2022 Q4	$35K	Sell	5,543 -208	-4%	-$2.59K	﹤0.01%	2478
2022 Q3	$36K	Hold	5,751	–	–	﹤0.01%	2629
2022 Q2	$36K	Hold	5,751	–	–	﹤0.01%	2393
2022 Q1	$36K	Buy	5,751 +5,673	+7,273%	+$91K	﹤0.01%	2393
2021 Q4	$1K	Sell	78 -460	-86%	-$6.09K	﹤0.01%	2940
2021 Q3	$7K	Sell	538 -8,284	-94%	-$131K	﹤0.01%	2402
2021 Q2	$140K	Buy	8,822 +2,723	+45%	+$37K	﹤0.01%	1077
2021 Q1	$63K	Sell	6,099 -1,196	-16%	-$12.3K	﹤0.01%	1357
2020 Q4	$55K	Buy	7,295 +5,095	+232%	+$26.3K	﹤0.01%	1401
2020 Q3	$7K	Buy	+2,200	New	+$9.43K	﹤0.01%	2024
2020 Q2	–	Hold	0	–	–	–	2815
2020 Q1	–	Hold	0	–	–	–	2835
2019 Q4	–	Hold	0	–	–	–	2897
2019 Q3	–	Hold	0	–	–	–	3121
2017 Q4	–	Sell	-1,000	Closed	-$5K	–	3813
2017 Q3	$5K	Hold	1,000	–	–	﹤0.01%	3364
2017 Q2	$6K	Hold	1,000	–	–	﹤0.01%	3281
2017 Q1	$8K	Hold	1,000	–	–	﹤0.01%	3029
2016 Q4	$6K	Hold	1,000	–	–	﹤0.01%	3177
2016 Q3	$4K	Hold	1,000	–	–	﹤0.01%	3303
2016 Q2	$3K	Buy	+1,000	New	+$3.1K	﹤0.01%	3322
2016 Q1	–	Sell	-1,000	Closed	-$10K	–	2442
2015 Q4	$10K	Buy	+1,000	New	+$9.94K	﹤0.01%	2570